Evidence map›Paper›PMID 34330903›Full record

ArticleNature communications2021

Structural basis for +1 ribosomal frameshifting during EF-G-catalyzed translocation.

Gabriel Demo, Howard B Gamper, Anna B Loveland, Isao Masuda, Christine E Carbone, Egor Svidritskiy, Ya-Ming Hou, Andrei A Korostelev

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Recoding by NNature communications · 2026
    Article
  2. eLife · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. The Structural and Molecular Mechanisms ofMolecules (Basel, Switzerland) · 2024
    Review
  10. The role of GTP hydrolysis by EF-G in ribosomal translocation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Article
  12. The Structural Dynamics of Translation.Annual review of biochemistry · 2022
    Review
  13. Review
  14. Extraintestinal PathogenicMicrobiology spectrum · 2022
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Loss ofeLife · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gabriel DemoRNA Therapeutics Institute, Department of Biochemistry and Molecular Pharmacology, UMass Medical School, Worcester, MA, USA.
Howard B GamperDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA.ORCID 0000-0001-9007-8546
Anna B LovelandRNA Therapeutics Institute, Department of Biochemistry and Molecular Pharmacology, UMass Medical School, Worcester, MA, USA.ORCID 0000-0001-9172-7747
Isao MasudaDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA.ORCID 0000-0001-9385-4424
Christine E CarboneRNA Therapeutics Institute, Department of Biochemistry and Molecular Pharmacology, UMass Medical School, Worcester, MA, USA.
Egor SvidritskiyRNA Therapeutics Institute, Department of Biochemistry and Molecular Pharmacology, UMass Medical School, Worcester, MA, USA.
Ya-Ming HouDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA. Ya-Ming.Hou@jefferson.edu.ORCID 0000-0001-6546-2597
Andrei A KorostelevRNA Therapeutics Institute, Department of Biochemistry and Molecular Pharmacology, UMass Medical School, Worcester, MA, USA. Andrei.Korostelev@umassmed.edu.ORCID 0000-0003-1588-717X

Funding

Translational Control: Discovery and MechanismsR35GM127094 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Andrei Korostelev · 2018 to 2026
$5.5M
tRNA in codon usageR35GM134931 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI HOU, YA-MING · 2020 to 2025
$5.4M
TrmD-targeting actinobacterial natural products as next generation antibioticsR01AI164490 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI HOU, YA-MING, SHEN, BEN · 2021 to 2025
$4.2M
Discovery of Gram-negative permeable chemical probes for tRNA methylationR01AI139202 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI HOU, YA-MING · 2019 to 2022
$2.4M
Structural bases for cellular stress responses mediated by stalled translationR01GM106105 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KOROSTELEV, ANDREI · 2013 to 2017
$1.6M
Molecular principles of translation terminationR01GM107465 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KOROSTELEV, ANDREI · 2015 to 2018
$1.3M
Elucidating premature translation termination in Cystic FibrosisF31HL152650 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CARBONE, CHRISTINE ELIZABETH · 2020 to 2022
$86k
NHLBI NIH HHS F31 HL152650NIAID NIH HHS R01 AI139202NIAID NIH HHS R01 AI164490NIGMS NIH HHS R01 GM106105NIGMS NIH HHS R01 GM107465NIGMS NIH HHS R35 GM127094NIGMS NIH HHS R35 GM134931
6 · The paper itself

Abstract

Frameshifting of mRNA during translation provides a strategy to expand the coding repertoire of cells and viruses. How and where in the elongation cycle +1-frameshifting occurs remains poorly understood. We describe seven ~3.5-Å-resolution cryo-EM structures of 70S ribosome complexes, allowing visualization of elongation and translocation by the GTPase elongation factor G (EF-G). Four structures with a + 1-frameshifting-prone mRNA reveal that frameshifting takes place during translocation of tRNA and mRNA. Prior to EF-G binding, the pre-translocation complex features an in-frame tRNA-mRNA pairing in the A site. In the partially translocated structure with EF-G•GDPCP, the tRNA shifts to the +1-frame near the P site, rendering the freed mRNA base to bulge between the P and E sites and to stack on the 16S rRNA nucleotide G926. The ribosome remains frameshifted in the nearly post-translocation state. Our findings demonstrate that the ribosome and EF-G cooperate to induce +1 frameshifting during tRNA-mRNA translocation.

Indexed as

BiocatalysisCryoelectron MicroscopyEscherichia coliEscherichia coli ProteinsFrameshifting, RibosomalModels, MolecularNucleic Acid ConformationPeptide Chain Elongation, TranslationalPeptide Elongation Factor GProtein ConformationRibosomesRNA, MessengerRNA, Ribosomal, 16SRNA, TransfertRNA MethyltransferasesEscherichia coli ProteinsPeptide Elongation Factor GRNA, MessengerRNA, Ribosomal, 16SRNA, TransferTrmD protein, E colitRNA Methyltransferases

Identifiers

PMID34330903
PMCPMC8324841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.